Absence of Non-Canonical, Inhibitory MYD88 Splice Variants in B Cell Lymphomas Correlates With Sustained NF-κB Signaling

Overview of attention for article published in Frontiers in immunology, June 2021

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (70th percentile)
Good Attention Score compared to outputs of the same age and source (73rd percentile)

Mentioned by

twitter: 5 X users

f1000: 1 research highlight platform

Readers on

mendeley: 15 Mendeley

Summary X Research highlights

So far, Altmetric has seen 6 X posts from 5 X users, with an upper bound of 36,669 followers.

RT @cardona_yamel: My 2nd first Author paper 🎉🎉is published. MyD88 splicing in B cell Lymphomas as novel target for NF-kB addicted NHLs. C…

01 Oct 2021

Reply Repost Favourite

My 2nd first Author paper 🎉🎉is published. MyD88 splicing in B cell Lymphomas as novel target for NF-kB addicted NHLs. Check it out! https://t.co/fcQ4wKYgwj #immunology #Lymphoma #medicine

16 Aug 2021

Reply Repost Favourite

Absence of Non-Canonical, Inhibitory MYD88 Splice Variants in B Cell Lymphomas Correlates With Sustained NF-kappaB Signaling #lymphoma #lymsm https://t.co/zL0bAEKim0

25 Jun 2021

Reply Repost Favourite

New article: Absence of Non-Canonical, Inhibitory MYD88 Splice Variants in B Cell Lymphomas Correlates With Sustained NF-kappaB Signaling https://t.co/tnNvqxyTAN #DLBCL #lymsm #hematology https://t.co/vO6du6a0Me

24 Jun 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.